Bio-Rad Laboratories (Canada) Ltd, 1329 Meyerside Dr, Mississauga, ON, L5T 1C9, Canada,
Mol Biotechnol. 2013 Nov;55(3):217-26. doi: 10.1007/s12033-013-9672-6.
Chemiluminescent western blotting has been in common practice for over three decades, but its use as a quantitative method for measuring the relative expression of the target proteins is still debatable. This is mainly due to the various steps, techniques, reagents, and detection methods that are used to obtain the associated data. In order to have confidence in densitometric data from western blots, researchers should be able to demonstrate statistically significant fold differences in protein expression. This entails a necessary evolution of the procedures, controls, and the analysis methods. We describe a methodology to obtain reliable quantitative data from chemiluminescent western blots using standardization procedures coupled with the updated reagents and detection methods.
化学发光免疫印迹法已经有三十多年的应用历史了,但它作为一种测量目标蛋白相对表达量的定量方法仍然存在争议。这主要是因为在获得相关数据时,所使用的步骤、技术、试剂和检测方法各不相同。为了对免疫印迹法的密度测定数据有信心,研究人员应该能够证明蛋白质表达的统计学显著倍数差异。这需要对程序、对照和分析方法进行必要的改进。我们描述了一种使用标准化程序以及更新的试剂和检测方法从化学发光免疫印迹法中获得可靠定量数据的方法。